# ProPhase Labs, Inc.: filings

PRPH · OTC · CIK 868278 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/prph.md) · [Financials](/companies/prph/financials.md) · [Filings](/companies/prph/filings.md) · [Insiders](/companies/prph/insiders.md)

## Reports and events: 400 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 242, 4 150, 10-Q 53, SC 13D/A 35, DEF 14A 21, 10-K 18, UPLOAD 18, CORRESP 14, DEFA14A 14, 3 13, DFAN14A 13, 8-K/A 12, S-8 12, 424B5 11, EFFECT 10, 4/A 8, NT 10-Q 8, SC 13D 8, S-3 7, 10-Q/A 6, ARS 6, PRE 14A 6, SC 13G/A 6, 10-K/A 4, D 4, SC 13G 4, SC TO-I/A 4, NT 10-K 3, POS AM 3, 424B3 2, 8-A12G/A 2, FWP 2, PRER14A 2, PRRN14A 2, SC TO-I 2, 15-12G 1, 25-NSE 1, 3/A 1, CT ORDER 1, DEFC14A 1, PREC14A 1, PREN14A 1, S-1 1, S-8 POS 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-19 | 20:31 ET | [10-Q](/filings/0001493152-26-039224.md) | Quarterly report, period 2026-06-30 | 0001493152-26-039224 |
| 2026-08-06 | 21:00 ET | [8-K](/filings/0001493152-26-036383.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-26-036383 |
| 2026-07-09 | 19:12 ET | [10-Q/A](/filings/0001493152-26-032658.md) | Quarterly report, amended, period 2026-03-31 | 0001493152-26-032658 |
| 2026-07-07 | 13:23 ET | [10-Q/A](/filings/0001493152-26-032269.md) | Quarterly report, amended, period 2026-03-31 | 0001493152-26-032269 |
| 2026-06-30 | 20:50 ET | [10-Q](/filings/0001493152-26-031301.md) | Quarterly report, period 2026-03-31 | 0001493152-26-031301 |
| 2026-06-01 | 21:13 ET | [10-K](/filings/0000868278-26-000005.md) | Annual report, period 2025-12-31 | 0000868278-26-000005 |
| 2026-02-13 | 22:15 ET | [8-K](/filings/0001493152-26-006784.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-006784 |
| 2026-02-13 | 22:15 ET | [8-K](/filings/0001493152-26-006785.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-006785 |
| 2026-01-27 | 16:06 ET | [8-K](/filings/0001493152-26-003724.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-003724 |
| 2026-01-23 | 22:20 ET | [8-K](/filings/0001493152-26-003460.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-003460 |
| 2026-01-23 | 22:15 ET | [8-K](/filings/0001493152-26-003456.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-003456 |
| 2026-01-09 | 22:15 ET | [8-K](/filings/0001493152-26-001143.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-001143 |
| 2026-01-09 | 22:10 ET | [8-K](/filings/0001493152-26-001134.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-001134 |
| 2026-01-02 | 22:10 ET | [8-K](/filings/0001493152-26-000175.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-26-000175 |
| 2025-12-19 | 20:37 ET | [8-K](/filings/0001493152-25-028537.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-028537 |
| 2025-12-19 | 18:07 ET | [8-K](/filings/0001493152-25-028483.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-028483 |
| 2025-12-18 | 18:30 ET | [8-K/A](/filings/0001493152-25-028317.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-028317 |
| 2025-12-12 | 16:41 ET | [8-K/A](/filings/0001493152-25-027399.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-027399 |
| 2025-12-12 | 23:07 ET | [8-K](/filings/0001493152-25-027317.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-027317 |
| 2025-11-26 | 19:15 ET | [8-K](/filings/0001493152-25-025102.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-025102 |
| 2025-11-25 | 21:30 ET | [8-K](/filings/0001493152-25-024986.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-024986 |
| 2025-11-25 | 21:30 ET | [8-K](/filings/0001493152-25-024988.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-024988 |
| 2025-11-19 | 21:06 ET | [10-Q](/filings/0000868278-25-000017.md) | Quarterly report, period 2025-09-30 | 0000868278-25-000017 |
| 2025-11-19 | 14:00 ET | [8-K](/filings/0001493152-25-024174.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-024174 |
| 2025-10-31 | 21:38 ET | [DEF 14A](/filings/0001493152-25-020375.md) | Proxy statement, period 2025-10-31 | 0001493152-25-020375 |
| 2025-10-21 | 21:29 ET | [S-1](/filings/0001493152-25-018819.md) | Registration statement | 0001493152-25-018819 |
| 2025-10-15 | 18:15 ET | [8-K](/filings/0001493152-25-018123.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-018123 |
| 2025-09-18 | 20:05 ET | [8-K](/filings/0001493152-25-014057.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-014057 |
| 2025-09-15 | 13:16 ET | [8-K](/filings/0001493152-25-013415.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-013415 |
| 2025-08-28 | 10:15 ET | [8-K](/filings/0001493152-25-012414.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-012414 |
| 2025-08-19 | 12:00 ET | [8-K](/filings/0001641172-25-024730.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-024730 |
| 2025-08-15 | 21:08 ET | [DEF 14A](/filings/0001641172-25-024375.md) | Proxy statement, period 2025-08-15 | 0001641172-25-024375 |
| 2025-08-13 | 21:07 ET | [10-Q](/filings/0000868278-25-000011.md) | Quarterly report, period 2025-06-30 | 0000868278-25-000011 |
| 2025-08-13 | 13:00 ET | [8-K](/filings/0001641172-25-023344.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-023344 |
| 2025-08-06 | 20:10 ET | [8-K](/filings/0001641172-25-022426.md) | 5.02 Departure or appointment of officers or directors | 0001641172-25-022426 |
| 2025-07-29 | 12:00 ET | [8-K](/filings/0001641172-25-021262.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021262 |
| 2025-07-28 | 12:20 ET | [8-K](/filings/0001641172-25-021109.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021109 |
| 2025-07-25 | 23:15 ET | [8-K](/filings/0001641172-25-020898.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001641172-25-020898 |
| 2025-07-23 | 12:00 ET | [8-K](/filings/0001641172-25-020651.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-020651 |
| 2025-07-21 | 12:00 ET | [8-K](/filings/0001641172-25-020357.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-020357 |
| 2025-07-01 | 13:00 ET | [8-K](/filings/0001641172-25-017286.md) | 3.01 Delisting notice | 0001641172-25-017286 |
| 2025-06-27 | 13:00 ET | [8-K/A](/filings/0001641172-25-016815.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-016815 |
| 2025-06-26 | 21:25 ET | [8-K](/filings/0001641172-25-016710.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-016710 |
| 2025-06-26 | 21:14 ET | [8-K](/filings/0001641172-25-016692.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-016692 |
| 2025-06-25 | 21:07 ET | [8-K](/filings/0001641172-25-016501.md) | 5.02 Departure or appointment of officers or directors | 0001641172-25-016501 |
| 2025-06-23 | 13:00 ET | [DEF 14A](/filings/0001641172-25-016010.md) | Proxy statement, period 2025-06-23 | 0001641172-25-016010 |
| 2025-05-20 | 20:06 ET | [10-Q](/filings/0000868278-25-000007.md) | Quarterly report, period 2025-03-31 | 0000868278-25-000007 |
| 2025-05-20 | 12:00 ET | [8-K](/filings/0001641172-25-011607.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-011607 |
| 2025-04-30 | 21:23 ET | [10-K/A](/filings/0001641172-25-007899.md) | Annual report, amended, period 2024-12-31 | 0001641172-25-007899 |
| 2025-04-01 | 21:33 ET | [10-K](/filings/0000868278-25-000003.md) | Annual report, period 2024-12-31 | 0000868278-25-000003 |

Page 1 of 8. [Older](/companies/prph/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.